Key facts
- This page summarizes Jack W. Schuler's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Jul 2024, 18:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
Footnote F2
The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.
Footnote F3
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Footnote F4
On June 28, 2023, the reporting person was granted a total of 23,684 RSUs, which vest in five equal annual installments beginning on June 28, 2024.